Remus Pharmaceuticals Limited is coming up with the book-built issue of equity shares in the IPO (Initial Public Offering). Remus Pharmaceuticals IPO is expected to be issued from 17th May to 19th May 2023. 3,88,000 equity shares with a face value of Rs 10 per equity share are to be issued at ₹1150 to ₹1229 per share in this IPO. Let’s delve deeper into this upcoming IPO issue in May 2023.
About Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited, founded in 2015, is a visionary company in the pharmaceutical industry. They specialize in marketing and distributing transformative drugs, including Active Pharmaceutical Ingredients (APIs) and Finished Pharmaceutical Formulations. With an impressive portfolio of 429 products, they have established a global presence under various brand names.
The company has nurtured strong relationships with 58 domestic distributors and 139 international distributors. Their esteemed clientele spans over 20 countries and includes generic distributors, regional distributors, multinational distributors, hospitals, and clinics. Remus Pharmaceuticals is dedicated to bringing healing and hope to people worldwide.
Remus Pharmaceuticals IPO Issue Details
| Issue Type | Book Built IPO Issue |
| Issue Opens | 17th May 2023 |
| Issue Closes | 19th May 2023 |
| Face Value | Rs 10 Per Share |
| Issue Price | Rs 1150 to Rs 1229 Per Share |
| Issue Size | 3,88,000 Shares (Rs 47.69 crores) |
| Minimum Order Quantity | 100 Shares |
| Listing | NSE, SME |
Purpose of the Issue
The company plans to put the net proceeds from the issue toward funding the following initiatives:
- In order to address working capital needs, finance acquisitions, and fulfill general corporate objectives
- They intend to allocate resources towards covering expenses related to public issues.
Company Contact Details
- Registered & Corporate Office: 1101 to 1103, South Tower, One 42, B/H Ashok Vatika, Nr. Jayantilal Park BRTS, Ambli bopal Road, Ahmedabad – 380054
- Telephone: +079- 2999 9857
- Website: http://remuspharma.com/
Remus Pharmaceuticals Limited IPO – Lead Managers of the Issue
Beeline Capital Advisors Private Limited
- Office Address: : B 1311-1314, Thirteenth Floor, Shilp Corporate Park, Rajpath Rangoli Road, Thaltej, Ahmadabad, Gujarat – 380054
- Telephone: +91 079 4840 7357
- Email: mb@beelinemb.com
Remus Pharmaceuticals IPO – Registrar of the Issue
The registrar of this IPO issue is Link Intime India Private Ltd
- Telephone: +91-22-4918 6270
- Email: remuspharmaceuticals.ipo@linkintime.co.in
- Website: https://linkintime.co.in/
Remus Pharmaceuticals Limited IPO Issue Prospectus
Click here to read the Final Prospectus of this IPO Issue.
